期刊文献+

经皮间隔心肌化学消融治疗肥厚性梗阻型心肌病的观察及护理

下载PDF
导出
作者 袁静 戴红兰
出处 《实用医学杂志》 CAS 2002年第12期1355-1355,共1页 The Journal of Practical Medicine
  • 相关文献

参考文献3

二级参考文献13

  • 1[4]Kazmierczak J,Kornacewixz J Z,Kisly M,et al.Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.Heart,1998,80(3):257-262.
  • 2[5]Tsuchikane E,Nakamura T,Yamazaki K,et al.Transluminal percutanious septal myocardial ablation in a patient with hypertrophic obstructive cardiom-yopathy.Jpn Circ J,1998,63(7):537-540.
  • 3[6]Gspar J,Mrtiez R M A,Vonderwaide C,et al.Pericardium-covered stent for septa;myocardial ablation in hypertrophic obstructive cardiomyopathy.Cathet Cardiovasc lnterv,1999,47(1):73-79.
  • 4[7]Gaber L,Seggewiss H,Ziemssen P,et al.lntraprocedural myocardial contrast echocaediography as a routine procedure in percutaneous transluminal septal myocardial ablation:Detection of threatening myocardial necrosis distant from the septal target area.Cathet Cardiovasc Interv,1999,47(4):462-466.
  • 5[8]Feber L,Seggwiss H,Gleichmann U.Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy:Results with respect to intraprocedural myocardial contrast echocardiography.Circulation,1998,96(22):2415-2421.
  • 6[9]Seggewiss H,Gaber L, Gleichmann U.Percutaneous transluminal septal ablation hypertrophic obstructive cardiomyopathy.Thorac Cardiovasc Surg,1999,47(2):94-100.
  • 7[10]Gietzen F H,Leuner C J,Raute K U,et al.Acute and long-term results after transcoronary ablation of septal hypertrophy[TASH].Catheter interventional treatment for hypertrophic obstructive cardio-myopathy.Eur Heart J,1999,20(18):1342-1354.
  • 8[11]Kin J J,Lee C W,Park S W,et al.lmprovement in exercise capacity and exercise blood prssure response after transcoronary alcochol ablation of septal hypertrophy in phypertrophic cardiomyopathy.Am J Cardiol,1999,83(8):1220-1223.
  • 9[12]Kuhm H,Gietzen F H,Schers M,et al.Changes in the left ventricular outflow tract after transcoronary ablation of setal hypertrophy[TASH]for hypertrophic obstructive cardiomyopathy as assessed by transeso-phageal echocardiography and by measurintg myocardial glucose utilization and perfusion.Eur Heart J,1999,20(24):1808-1817.
  • 10[13]Seggewiss H,Gaber L,Meyners W,et al.Simultaneous percutaneous treatment in hypertrophic cardiom-yopathy and coronaty artery disease:A case report.Cathet Cardiovasc Diagn,1998,44(1):65-69.

共引文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部